Protagonist Therapeutics (NASDAQ:PTGX) Given Buy Rating at HC Wainwright
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s price objective suggests a potential upside of 87.71% from the company’s current price. PTGX […]
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s price objective suggests a potential upside of 87.71% from the company’s current price. PTGX […]
